252 related articles for article (PubMed ID: 21953116)
1. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.
Davidsson S; Fiorentino M; Andrén O; Fang F; Mucci LA; Varenhorst E; Fall K; Rider JR
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2280-7. PubMed ID: 21953116
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
3. Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.
Meyer F; Têtu B; Bairati I; Lacombe L; Fradet Y
Can J Urol; 2006 Oct; 13(5):3255-60. PubMed ID: 17076947
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome is not associated with greater evidences of proliferative inflammatory atrophy and inflammation in patients with suspected prostate cancer.
Russo GI; Cimino S; Giranio G; Regis F; Favilla V; Privitera S; Motta F; Caltabiano R; Stenzl A; Todenhöfer T; Morgia G
Urol Oncol; 2018 May; 36(5):240.e21-240.e26. PubMed ID: 29429896
[TBL] [Abstract][Full Text] [Related]
5. A unifying hypothesis that links benign prostatic hyperplasia and prostatic intraepithelial neoplasia with prostate cancer. Invited comments.
Harvey H
Pathol Res Pract; 1995 Sep; 191(9):924-34. PubMed ID: 8606875
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
[TBL] [Abstract][Full Text] [Related]
7. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
[TBL] [Abstract][Full Text] [Related]
8. Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: a biopsy study in chronic prostatitis patients.
Vral A; Magri V; Montanari E; Gazzano G; Gourvas V; Marras E; Perletti G
Int J Oncol; 2012 Dec; 41(6):1950-8. PubMed ID: 23026863
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer.
Zhang Y; Zhou CK; Rencsok EM; Fall K; Lotan TL; Loda M; Giunchi F; Platz EA; De Marzo AM; Mucci LA; Fiorentino M; Ebot EM
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2047-2054. PubMed ID: 31533941
[TBL] [Abstract][Full Text] [Related]
10. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis.
Di Silverio F; Gentile V; De Matteis A; Mariotti G; Giuseppe V; Luigi PA; Sciarra A
Eur Urol; 2003 Feb; 43(2):164-75. PubMed ID: 12565775
[TBL] [Abstract][Full Text] [Related]
11. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer.
Giunchi F; Jordahl K; Bollito E; Colecchia M; Patriarca C; D'Errico A; Vasuri F; Malvi D; Fornari A; Bonetti LR; Corti B; Papotti M; DeGiuli P; Loda M; Montironi R; Fiorentino M; Rider JR
Virchows Arch; 2017 Jun; 470(6):711-715. PubMed ID: 28405833
[TBL] [Abstract][Full Text] [Related]
12. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
[TBL] [Abstract][Full Text] [Related]
13. Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia.
Merrimen JL; Evans AJ; Srigley JR
Pathology; 2013 Apr; 45(3):251-63. PubMed ID: 23478231
[TBL] [Abstract][Full Text] [Related]
14. FOXP3
Davidsson S; Andren O; Ohlson AL; Carlsson J; Andersson SO; Giunchi F; Rider JR; Fiorentino M
Prostate; 2018 Jan; 78(1):40-47. PubMed ID: 29105795
[TBL] [Abstract][Full Text] [Related]
15. Prostate elastosis: a microscopic feature useful for the diagnosis of postatrophic hyperplasia.
Billis A; Magna LA
Arch Pathol Lab Med; 2000 Sep; 124(9):1306-9. PubMed ID: 10975927
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.
Kryvenko ON; Jankowski M; Chitale DA; Tang D; Rundle A; Trudeau S; Rybicki BA
Mod Pathol; 2012 Jul; 25(7):1023-32. PubMed ID: 22460812
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
[TBL] [Abstract][Full Text] [Related]
18. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
19. Prostatic intraepithelial neoplasia and the origins of prostatic carcinoma.
Bostwick DG; Montironi R
Pathol Res Pract; 1995 Sep; 191(9):828-32. PubMed ID: 8606858
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]